(Q73065149)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

M Kitagawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Mitsui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Nakamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Yoshino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Miyakawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N Ochiai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Onobori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Suzuki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

T Sumida

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1917-1926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10513808%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The role of IL-12 in the induction of organ-specific autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Th1/Th2 cytokine balance in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Functional CD40 ligand is expressed by T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199909%2942%3A9%3C1917%3A%3AAID-ANR18%3E3.0.CO%3B2-2

10.1002/1529-0131(199909)42:9<1917::AID-ANR18>3.0.CO;2-2

21 January 2018

Identifiers

DOI

0 references

1 reference